Taking people in SvájcNo phase
Swiss Primary Biliary Cholangitis Cohort Study
Key facts
- Where
- Basel, Bern, Bülach, Chur, Geneva, Lausanne, Liestal, Lucerne, Lugano, Sankt Gallen, Winterthur és Zurich, SvájcSee the 13 sites
Where in Svájc
- Gastroenterologie und Hepatologie, Clarunis - Universitäres Bauchzentrum BaselBasel, SvájcTaking people
- InselspitalBern, SvájcTaking people
- Spital BülachBülach, SvájcTaking people
- Kantonsspital GraubundenChur, SvájcTaking people
- Hôpitaux Universitaires de Genève, Service de Gastroentérologie & Hépatologie, Département des SpécialitésGeneva, SvájcTaking people
- CHUV (centre hospitalier universitaire vaudois)Lausanne, SvájcTaking people
- Kantonsspital BasellandLiestal, SvájcTaking people
- Luzerner KantonsspitalLucerne, SvájcTaking people
- EOC Ospedale Regionale di Lugano - ItalianoLugano, SvájcTaking people
- Fondazione Epatocentro TicinoLugano, SvájcTaking people
- Kantonsspital St. GallenSankt Gallen, SvájcTaking people
- Kantonsspital WinterthurWinterthur, SvájcTaking people
- Universitätsspital ZürichZurich, SvájcTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Fondazione Epatocentro Ticino
- Trial code
- NCT03146910
- Record updated
- 2025. augusztus 17.
- Original description
Research project in which biological material is sampled and health-related medical data is collected. In addition, already existing health-related medical data are used for further research. Coded data are used.Read full original descriptionShow less
Research project in which biological material is sampled and health-related medical data is collected. In addition, already existing health-related medical data are used for further research. Coded data are used.
Inclusion: diagnose of Primary biliary cholangitis (according to EASL Clinical Practice Guidelines: management of cholestatic liver diseases); Subjects with isolated anti-mitochondrial antibodies and/or isolated PBC-specific anti-nuclear antibodies are also included; Patients/subjects aged at least 18 years and living in Switzerland are included.
Exclusion: N/A.